X4 Pharmaceuticals, Inc (XFOR) Operating Lease, Payments USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
X4 Pharmaceuticals, Inc quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2024.
  • X4 Pharmaceuticals, Inc Operating Lease, Payments for the quarter ending March 31, 2024 was $344 K, a 0.58% decline year-over-year.
  • X4 Pharmaceuticals, Inc Operating Lease, Payments for the twelve months ending March 31, 2024 was $1.38 M, a 1.84% increase year-over-year.
  • X4 Pharmaceuticals, Inc annual Operating Lease, Payments for 2023 was $1.39 M, a 2.29% increase from 2022.
  • X4 Pharmaceuticals, Inc annual Operating Lease, Payments for 2022 was $1.35 M, a 7.72% increase from 2021.
  • X4 Pharmaceuticals, Inc annual Operating Lease, Payments for 2021 was $1.26 M, a 67.1% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.38 M $344 K -$2 K -0.58% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.39 M $349 K +$9 K +2.65% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $1.38 M $345 K +$11 K +3.29% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.37 M $345 K +$7 K +2.07% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.36 M $346 K +$4 K +1.17% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $1.35 M $340 K $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $1.35 M $334 K +$20 K +6.37% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.33 M $338 K +$58 K +20.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.28 M $342 K +$19 K +5.88% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $1.26 M $340 K -$2.52 M -88.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-21
Q3 2021 $3.77 M $314 K -$165 K -34.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $3.94 M $280 K +$38 K +15.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $3.9 M $323 K +$81 K +33.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $3.82 M $2.86 M +$2.59 M +950% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-21
Q3 2020 $1.24 M $479 K +$211 K +78.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $1.02 M $242 K -$24 K -9.02% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $1.05 M $242 K +$41 K +20.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $1.01 M $272 K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-17
Q3 2019 $268 K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $266 K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $201 K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.